Trial Profile
Phase I trial investigating vismodegib in Japan
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 23 Feb 2010
Price :
$35
*
At a glance
- Drugs Vismodegib (Primary)
- Indications Colorectal cancer; Ovarian cancer
- Focus Adverse reactions
- Sponsors Chugai Pharmaceutical
- 23 Feb 2010 New trial record